{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:29:27Z","timestamp":1791919767256,"version":"4.3.4"},"reference-count":38,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"\nOBJECTIVE<\/jats:title>\nRecently, the authors have reported the 5-year risk of stroke in patients with asymptomatic moyamoya disease (MMD). In this report, the aim was to clarify patients\u2019 5-year risk of disease progression, transient ischemic attack (TIA), and de novo parenchymal lesions and to identify their predictors.<\/jats:p>\n<\/jats:sec>\n\nMETHODS<\/jats:title>\nThis multicenter, prospective cohort study (Asymptomatic Moyamoya Registry [AMORE]) in Japan is still ongoing. Participants were enrolled if they were 20\u201370 years of age, had bilateral or unilateral MMD, experienced no episodes suggestive of TIA and stroke, were functionally independent (modified Rankin Scale score of 0 or 1), and had been followed up for 10 years. Clinical and radiological data were obtained at enrollment and annually thereafter for 5 years. In this 5-year interim analysis, the authors defined disease progression, TIA, and de novo parenchymal lesions as the secondary endpoints. The predictors for these events were identified, using a stratification analysis method.<\/jats:p>\n<\/jats:sec>\n\nRESULTS<\/jats:title>\nA total of 103 patients were enrolled and prospectively followed up for 5 years. On annual MRA examinations, disease progression occurred in 39 hemispheres in 26 patients. The incidence of disease progression was 5.9% per patient-year, and the predictors included younger age (OR 5.72, 95% CI 1.28\u201325.56; p = 0.0223) and hypercholesterolemia (OR 5.41, 95% CI 1.37\u201321.28; p = 0.0158). TIA occurred in 12 hemispheres in 10 patients, for an incidence of 2.3% per patient-year. The disease progression prior to TIA was a significant predictor for TIA (OR 5.00, 95% CI 1.31\u201319.0; p = 0.0184). De novo microbleeds were found in 11 hemispheres in 10 patients (2.3% per patient-year). The presence of microbleeds at enrollment was a significant predictor for de novo microbleeds (OR 5.53, 95% CI 1.17\u201326.13; p = 0.0309).<\/jats:p>\n<\/jats:sec>\n\nCONCLUSIONS<\/jats:title>\nPatients with asymptomatic MMD may carry a significant risk of disease progression, TIA, and de novo microbleeds during the first 5 years after initial diagnosis. Practitioners should very carefully follow up with them to improve their outcome, using MRI and MRA at regular intervals.<\/jats:p>\nClinical trial registration no.: UMIN000006640 (https:\/\/www.umin.ac.jp<\/jats:ext-link>).<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.6.jns24736","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T01:32:12Z","timestamp":1729301532000},"page":"1-9","source":"Crossref","is-referenced-by-count":4,"title":["Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study"],"prefix":"10.3171","author":[{"given":"Satoshi","family":"Kuroda","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Funaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroharu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Cerebral and Cardiovascular Center, Suita;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Hishikawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kawasaki Medical School, Kurashiki;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun C.","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kindai University School of Medicine, Sayama;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nariai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokyo Medical and Dental University, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Osato","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nakamura Memorial Hospital, Sapporo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, The University of Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Kashiwazaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi M.","family":"Ito","sequence":"additional","affiliation":[{"name":"Promotion Unit, Data Science Center, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto;"},{"name":"Moyamoya Disease Support Center, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Inaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoji","family":"Nakagawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hashimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eika","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mineharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhito","family":"Mase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikutaro","family":"Tokairin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiro","family":"Houkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Chida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kumabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"3","key":"b1","series-title":"Arch Neurol","first-page":"288","article-title":"Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki J","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u2013299."},{"issue":"11","key":"b2","series-title":"Lancet Neurol","first-page":"1056","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda S","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056\u20131066."},{"issue":"1","key":"b3","series-title":"J Neurosurg","first-page":"84","article-title":"Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease","volume":"77","author":"Karasawa J","year":"1992","unstructured":"Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 1992;77(1):84\u201389."},{"issue":"5","key":"b4","series-title":"Neurosurg Focus","first-page":"E5","article-title":"Long-term outcome after STA-MCA anastomosis for moyamoya disease","volume":"5","author":"Miyamoto S","year":"1998","unstructured":"Miyamoto S, Akiyama Y, Nagata I, Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus. 1998;5(5):E5."},{"issue":"5","key":"b5","series-title":"J Neurosurg Pediatr","first-page":"451","article-title":"Long-term follow-up of surgically treated juvenile patients with moyamoya disease","volume":"10","author":"Mukawa M","year":"2012","unstructured":"Mukawa M, Nariai T, Matsushima Y, Long-term follow-up of surgically treated juvenile patients with moyamoya disease. J Neurosurg Pediatr. 2012;10(5):451\u2013456."},{"key":"b6","series-title":"World Neurosurg","first-page":"e482","article-title":"Long-term outcomes after encephaloduroarteriosynangiosis in adult patients with moyamoya disease presenting with ischemia","volume":"115","author":"Bao XY","year":"2018","unstructured":"Bao XY, Zhang Y, Wang QN, Long-term outcomes after encephaloduroarteriosynangiosis in adult patients with moyamoya disease presenting with ischemia. World Neurosurg. 2018;115:e482\u2013e489."},{"issue":"6","key":"b7","series-title":"Neurol Med Chir (Tokyo)","first-page":"240","article-title":"Late cerebrovascular events and social outcome after adolescence: long-term outcome of pediatric moyamoya disease","volume":"58","author":"Funaki T","year":"2018","unstructured":"Funaki T, Takahashi JC, Miyamoto S. Late cerebrovascular events and social outcome after adolescence: long-term outcome of pediatric moyamoya disease. Neurol Med Chir (Tokyo). 2018;58(6):240\u2013246."},{"issue":"3","key":"b8","series-title":"J Neurosurg","first-page":"909","article-title":"Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease","volume":"134","author":"Kuroda S","year":"2020","unstructured":"Kuroda S, Nakayama N, Yamamoto S, Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease. J Neurosurg. 2020;134(3):909\u2013916."},{"issue":"5","key":"b9","series-title":"Stroke","first-page":"1415","article-title":"Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial","volume":"45","author":"Miyamoto S","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014;45(5):1415\u20131421."},{"issue":"1","key":"b10","series-title":"Stroke","first-page":"37","article-title":"Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial","volume":"47","author":"Takahashi JC","year":"2016","unstructured":"Takahashi JC, Funaki T, Houkin K, Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial. Stroke. 2016;47(1):37\u201343."},{"issue":"5","key":"b11","series-title":"Stroke","first-page":"1430","article-title":"Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan","volume":"38","author":"Kuroda S","year":"2007","unstructured":"Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38(5):1430\u20131435."},{"issue":"4","key":"b12","series-title":"No Shinkei Geka","first-page":"337","article-title":"Clinical features and outcomes in patients with asymptomatic moyamoya disease\u2014from the results of nation-wide questionnaire survey. Article in Japanese","volume":"33","author":"Yamada M","year":"2005","unstructured":"Yamada M, Fujii K, Fukui M. Clinical features and outcomes in patients with asymptomatic moyamoya disease\u2014from the results of nation-wide questionnaire survey. Article in Japanese. No Shinkei Geka. 2005;33(4):337\u2013342."},{"issue":"8","key":"b13","series-title":"J Neurol Neurosurg Psychiatry","first-page":"900","article-title":"Novel epidemiological features of moyamoya disease","volume":"79","author":"Baba T","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900\u2013904."},{"issue":"4","key":"b14","series-title":"Neurol Med Chir (Tokyo)","first-page":"165","article-title":"2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society","volume":"62","author":"Fujimura M","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo). 2022;62(4):165\u2013170."},{"issue":"10","key":"b15","series-title":"Stroke","first-page":"e465","article-title":"Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association","volume":"54","author":"Gonzalez NR","year":"2023","unstructured":"Gonzalez NR, Amin-Hanjani S, Bang OY, Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2023;54(10):e465\u2013e479."},{"issue":"3","key":"b16","series-title":"Neurol Med Chir (Tokyo)","first-page":"194","article-title":"Asymptomatic moyamoya disease: literature review and ongoing AMORE study","volume":"55","author":"Kuroda S","year":"2015","unstructured":"Kuroda S. Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurol Med Chir (Tokyo). 2015;55(3):194\u2013198."},{"issue":"6","key":"b17","series-title":"Stroke","first-page":"1494","article-title":"Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE)","volume":"54","author":"Kuroda S","year":"2023","unstructured":"Kuroda S, Yamamoto S, Funaki T, Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023;54(6):1494\u20131504."},{"issue":"10","key":"b18","series-title":"Stroke","first-page":"2148","article-title":"Incidence and clinical features of disease progression in adult moyamoya disease","volume":"36","author":"Kuroda S","year":"2005","unstructured":"Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005;36(10):2148\u20132153."},{"issue":"6","key":"b19","series-title":"Stroke","first-page":"2276","article-title":"Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease","volume":"40","author":"Easton JD","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40(6):2276\u20132293."},{"issue":"5","key":"b20","series-title":"Cerebrovasc Dis","first-page":"347","article-title":"Novel magnetic resonance angiography stage grading for moyamoya disease","volume":"20","author":"Houkin K","year":"2005","unstructured":"Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T. Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis. 2005;20(5):347\u2013354."},{"issue":"2","key":"b21","series-title":"Neurosurg Rev","first-page":"1553","article-title":"Angiographic disease progression in medically treated adult patients with ischemic moyamoya disease without cerebral misery perfusion: supplementary analysis of a 5-year prospective cohort","volume":"45","author":"Oomori D","year":"2022","unstructured":"Oomori D, Kubo Y, Yabuki M, Angiographic disease progression in medically treated adult patients with ischemic moyamoya disease without cerebral misery perfusion: supplementary analysis of a 5-year prospective cohort. Neurosurg Rev. 2022;45(2):1553\u20131561."},{"issue":"12","key":"b22","series-title":"No Shinkei Geka","first-page":"1291","article-title":"Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease. Article in Japanese","volume":"31","author":"Nanba R","year":"2003","unstructured":"Nanba R, Kuroda S, Takeda M, Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease. Article in Japanese. No Shinkei Geka. 2003;31(12):1291\u20131295."},{"issue":"2","key":"b23","series-title":"Cerebrovasc Dis","first-page":"94","article-title":"Clinical course of asymptomatic adult moyamoya disease","volume":"37","author":"Jo KI","year":"2014","unstructured":"Jo KI, Yeon JY, Hong SC, Kim JS. Clinical course of asymptomatic adult moyamoya disease. Cerebrovasc Dis. 2014;37(2):94\u2013101."},{"key":"b24","series-title":"World Neurosurg","first-page":"683","article-title":"Results of conservative follow-up or surgical treatment of moyamoya patients who present without hemorrhage, transient ischemic attack, or stroke","volume":"108","author":"Luo R","year":"2017","unstructured":"Luo R, Gao F, Deng X, Zhang D, Zhang Y. Results of conservative follow-up or surgical treatment of moyamoya patients who present without hemorrhage, transient ischemic attack, or stroke. World Neurosurg. 2017;108:683\u2013689."},{"key":"b25","series-title":"Front Nutr","first-page":"842838","article-title":"Cerebral ischemic complications after surgical revascularization for moyamoya disease: risk factors and development of a predictive model based on preoperative nutritional blood parameters","volume":"9","author":"Li F","year":"2022","unstructured":"Li F, Li C, Sun Y, Cerebral ischemic complications after surgical revascularization for moyamoya disease: risk factors and development of a predictive model based on preoperative nutritional blood parameters. Front Nutr. 2022;9:842838."},{"issue":"4","key":"b26","series-title":"J Neurosurg","first-page":"1005","article-title":"Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group","volume":"136","author":"Mineharu Y","year":"2021","unstructured":"Mineharu Y, Takagi Y, Koizumi A, Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the SUPRA Japan Study Group. J Neurosurg. 2021;136(4):1005\u20131014."},{"key":"b27","series-title":"World Neurosurg","first-page":"e146","article-title":"Asymptomatic moyamoya disease in a North American adult cohort","volume":"161","author":"Lai PMR","year":"2022","unstructured":"Lai PMR, Gomez-Paz S, Patel NJ, Asymptomatic moyamoya disease in a North American adult cohort. World Neurosurg. 2022;161:e146\u2013e153."},{"issue":"12","key":"b28","series-title":"Neurol Res","first-page":"1104","article-title":"Development of cerebral microbleeds and its impact on cognitive function in adult patients receiving medical management alone for ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort","volume":"44","author":"Yabuki M","year":"2022","unstructured":"Yabuki M, Kubo Y, Kitakami K, Development of cerebral microbleeds and its impact on cognitive function in adult patients receiving medical management alone for ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort. Neurol Res. 2022;44(12):1104\u20131112."},{"issue":"10","key":"b29","series-title":"Neurology","first-page":"e1086","article-title":"Distribution of cerebral microbleeds in the East and West: individual participant meta-analysis","volume":"92","author":"Yakushiji Y","year":"2019","unstructured":"Yakushiji Y, Wilson D, Ambler G, Distribution of cerebral microbleeds in the East and West: individual participant meta-analysis. Neurology. 2019;92(10):e1086\u2013e1097."},{"issue":"3","key":"b30","series-title":"J Neurosurg","first-page":"777","article-title":"Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial","volume":"128","author":"Funaki T","year":"2018","unstructured":"Funaki T, Takahashi JC, Houkin K, Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg. 2018;128(3):777\u2013784."},{"issue":"1","key":"b31","series-title":"Eur J Neurol","first-page":"163","article-title":"What is the expert\u2019s option on antiplatelet therapy in moyamoya disease? Results of a worldwide survey","volume":"19","author":"Kraemer M","year":"2012","unstructured":"Kraemer M, Berlit P, Diesner F, Khan N: What is the expert\u2019s option on antiplatelet therapy in moyamoya disease? Results of a worldwide survey. Eur J Neurol. 2012;19(1):163\u2013167."},{"issue":"2","key":"b32","series-title":"J Stroke Cerebrovasc Dis","first-page":"340","article-title":"Effects of surgery and antiplatelet therapy in ten-year follow-up from the Registry Study of Research Committee on Moyamoya Disease in Japan","volume":"25","author":"Yamada S","year":"2016","unstructured":"Yamada S, Oki K, Itoh Y, Effects of surgery and antiplatelet therapy in ten-year follow-up from the Registry Study of Research Committee on Moyamoya Disease in Japan. J Stroke Cerebrovasc Dis. 2016;25(2):340\u2013349."},{"issue":"4","key":"b33","series-title":"Neurosurg Focus","first-page":"E9","article-title":"Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions","volume":"55","author":"Abedi A","year":"2023","unstructured":"Abedi A, Sizdahkhani S, Choi W, Nguyen VN, Rennert RC, Russin JJ. Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions. Neurosurg Focus. 2023;55(4):E9."},{"key":"b34","series-title":"Front Neurol","first-page":"1132339","article-title":"Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis","volume":"14","author":"Liu T","year":"2023","unstructured":"Liu T, Qin M, Xiong X, Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis. Front Neurol. 2023;14:1132339."},{"issue":"8","key":"b35","series-title":"J Neurol","first-page":"3876","article-title":"Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study","volume":"270","author":"Luo Y","year":"2023","unstructured":"Luo Y, Cao Z, Ye H, Wu S, Sun X. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study. J Neurol. 2023;270(8):3876\u20133884."},{"issue":"5","key":"b36","series-title":"J Am Heart Assoc","first-page":"e017701","article-title":"Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study","volume":"10","author":"Seo WK","year":"2021","unstructured":"Seo WK, Kim JY, Choi EH, Association of antiplatelet therapy, including cilostazol, with improved survival in patients with moyamoya disease in a nationwide study. J Am Heart Assoc. 2021;10(5):e017701."},{"key":"b37","series-title":"Front Neurol","first-page":"608000","article-title":"Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease","volume":"11","author":"Ye F","year":"2021","unstructured":"Ye F, Li J, Wang T, Efficacy and safety of antiplatelet agents for adult patients with ischemic moyamoya disease. Front Neurol. 2021;11:608000."},{"issue":"1","key":"b38","series-title":"Stroke","first-page":"210","article-title":"Angiographic and hemodynamic features in asymptomatic hemispheres of patients with moyamoya disease","volume":"53","author":"Sun H","year":"2022","unstructured":"Sun H, Li W, Xia C, Angiographic and hemodynamic features in asymptomatic hemispheres of patients with moyamoya disease. Stroke. 2022;53(1):210\u2013217."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.6.JNS24736\/article-10.3171-2024.6.JNS24736.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.6.JNS24736\/article-10.3171-2024.6.JNS24736.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.6.JNS24736\/article-10.3171-2024.6.JNS24736.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T01:45:26Z","timestamp":1740793526000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.6.JNS24736\/article-10.3171-2024.6.JNS24736.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3171\/2024.6.jns24736","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}